Discontinued — last reported Q3 '25

Non-Current Assets

Equity Method Investments

Albemarle Equity Method Investments increased by 15.6% to $948.09M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 28.9%, from $735.77M to $948.09M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 4.6% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ3 2025

How to read this metric

An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.

Detailed definition

These are investments in entities where the company exercises significant influence but does not have full control. The...

Peer comparison

Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.

Metric ID: equity_method_investments

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$907.08M$902.50M$912.01M$937.62M$903.86M$1.16B$1.15B$1.39B$1.62B$1.25B$1.37B$1.26B$1.16B$1.18B$1.12B$735.77M$820.93M$838.73M$819.85M$948.09M
QoQ Change-0.5%+1.1%+2.8%-3.6%+28.2%-0.7%+20.9%+16.5%-22.7%+9.2%-8.1%-7.8%+1.6%-5.2%-34.2%+11.6%+2.2%-2.3%+15.6%
YoY Change-0.4%+28.4%+26.2%+48.4%+79.4%+8.2%+19.1%-9.5%-28.4%-5.9%-18.4%-41.6%-29.3%-28.9%-26.7%+28.9%
Range$735.77M$1.62B
CAGR+0.9%
Avg YoY Growth+3.1%
Median YoY Growth-3.1%

Business Segments

View all
SegmentQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Energy Storage$585.65M$663.22M$676.84M$737.79M$894.97M
Ketjen$140.92M$150.12M$157.71M$161.89M
Total$1.12B$735.77M$820.93M$838.73M$819.85M$948.09M

Ketjen was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.

Frequently Asked Questions

What is Albemarle's equity method investments?
Albemarle (ALB) reported equity method investments of $948.09M in Q1 2026.
How has Albemarle's equity method investments changed year-over-year?
Albemarle's equity method investments increased by 28.9% year-over-year, from $735.77M to $948.09M.
What is the long-term trend for Albemarle's equity method investments?
Over 5 years (2020 to 2025), Albemarle's equity method investments has grown at a 4.6% compound annual growth rate (CAGR), from $656.24M to $819.85M.
What does equity method investments mean?
The value of investments in other companies where the firm has significant influence but not total control.